Anti-Human CD38 Recombinant Antibody(Daratumumab)
-
产品编号
YR1199
-
别名
科研级Daratumumab, Anti-CD38 Recombinant Antibody, Research Grade Daratumumab
-
规格
- 1mg
- 5mg
产品介绍
| Alias | 科研级Daratumumab, Anti-CD38 Recombinant Antibody, Research Grade Daratumumab |
| Catalog Number | YR1199 |
| Molecular Name | Daratumumab |
| Size | 1mg, 5mg |
| Clonity | Monoclonal |
| Purity | >95% as determined by SDS-PAGE |
| Concentration | 1mg/ml |
| Antibody Isotype | IgG1 Kappa |
| Formulation | PBS, pH7.5 |
| Background | Daratumumab, sold under the brand name Darzalex, is an anti-cancer medication. It binds to CD38, which is overexpressed in multiple myeloma cells. Daratumumab was originally developed by Genmab, but it is now being jointly developed by Genmab along with the Johnson & Johnson subsidiary Janssen Biotech, which acquired worldwide commercialization rights to the drug from Genmab. |
| CAS Number | 945721-28-8 |
| Application | WB, IP, IF, FuncS, FCM, Neut, ELISA |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Remarks | This product is for research use only. |
| Shipping Condition | Shipped on ice packs. |
| Molecular Weight | 148 kDa |
| Target | CD38[Homo sapiens] |
- 联系我们
- 电话：400-621-6806
- 手机：13116038708
- 邮箱：info@kmdbioscience.com
- 地址：天津市武清区国际企业社区A5号楼
-
销售微信
-
官方公众号
-
400-621-6806 -
614353794 -
周一至周五 9:00-18:00 -
-
0
-
